Cargando…
Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients
INTRODUCTION: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare demyelinating disorder of the central nervous system. Despite increased recognition of MOGAD as a distinct disease and the availability of sensitive methods of MOG antibody testing, diagnostic challenges...
Autores principales: | Santoro, Jonathan D., Gould, Jennifer, Panahloo, Zoya, Thompson, Ella, Lefelar, Julia, Palace, Jacqueline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310677/ https://www.ncbi.nlm.nih.gov/pubmed/37024731 http://dx.doi.org/10.1007/s40120-023-00474-9 |
Ejemplares similares
-
Publisher Correction: Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients
por: Santoro, Jonathan D., et al.
Publicado: (2023) -
Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD)
por: Li, Yunjie, et al.
Publicado: (2022) -
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges
por: Al-Ani, Abdullah, et al.
Publicado: (2023) -
High fever in myelin oligodendrocyte
glycoprotein-associated disorder (MOGAD):
A diagnostic challenge
por: Azar, Chadi, et al.
Publicado: (2023) -
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)
por: Lotan, Itay, et al.
Publicado: (2023)